Similar to most NaV1.7 mutations that cause primary erythromelalgia, I136V mutation significantly decreases the deactivation rate of sodium currents at all tested deactivation potentials (Figure 2A). This evidence concerns the gene SCN9A and sodium channelopathy-related small fiber neuropathy.